sec filing
EL
NASDAQ · ELAB
PMGC Holdings Inc.
Healthcare · Biotechnology
$4.60
Up+$0.02 (+0.42%)
Updated Sep 11, 2026, 6:34 PM
SID Score
3.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.71M
- P/E ratio
- -0.52
- Dividend yield
- 0.00%
- 52-week range
- $0.84 – $267.12
- Volume
- 17.84K
- Avg. volume
- 556.88K
Price performance
ELAB price history
1M range · 20 trading sessions · Daily adjusted prices
ELAB closed at $4.60 after 20 trading sessions, up 413.05% for the selected period.
- Last close
- $4.60
- Period change
- +413.05%
- Period low
- $0.90
- Period high
- $8.73
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $4.62 | $4.80 | $4.531 | $4.60 | 17.84K |
| Sep 9, 2026 | $4.80 | $4.8946 | $4.60 | $4.62 | 29.68K |
| Sep 8, 2026 | $5.21 | $5.35 | $4.8201 | $4.85 | 30.18K |
| Sep 4, 2026 | $5.17 | $5.35 | $5.17 | $5.21 | 16.12K |
| Sep 3, 2026 | $5.16 | $5.385 | $5.01 | $5.23 | 26.07K |
| Sep 2, 2026 | $4.99 | $5.3581 | $4.97 | $5.09 | 77.86K |
| Sep 1, 2026 | $5.15 | $5.30 | $5.03 | $5.03 | 53.82K |
| Aug 31, 2026 | $5.31 | $5.38 | $5.0597 | $5.19 | 28.79K |
| Aug 28, 2026 | $5.87 | $5.97 | $5.24 | $5.31 | 64.07K |
| Aug 27, 2026 | $6.05 | $6.0825 | $5.76 | $5.83 | 31.88K |
| Aug 26, 2026 | $5.60 | $6.20 | $5.59 | $6.05 | 48.11K |
| Aug 25, 2026 | $6.36 | $6.40 | $5.24 | $5.69 | 172.54K |
| Aug 24, 2026 | $6.85 | $6.85 | $6.0101 | $6.52 | 107.06K |
| Aug 21, 2026 | $6.60 | $7.29 | $5.98 | $6.66 | 204.02K |
| Aug 20, 2026 | $5.55 | $6.50 | $5.525 | $6.10 | 73.57K |
| Aug 19, 2026 | $8.72 | $8.72 | $5.40 | $5.603 | 205.1K |
| Aug 18, 2026 | $8.731 | $8.765 | $8.25 | $8.30 | 22.67K |
| Aug 17, 2026 | $9.30 | $9.30 | $8.555 | $8.73 | 14.51K |
| Aug 14, 2026 | $0.9133 | $0.96 | $0.90 | $0.91 | 601.57K |
| Aug 13, 2026 | $0.8918 | $0.92 | $0.8801 | $0.8966 | 242.65K |
Latest ELAB news
The latest Smart Investors Daily articles mentioning ELAB.
Stock researchMarket Activity · Short Interest
Loading stock research…